Analysis of Lesion Characteristics in the DANAMI-3-PRIMULTI Substudy
Research Background and Objectives The DANAMI-3-PRIMULTI trial has confirmed that in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), fractional flow reserve (FFR)-guided complete revascularization (FFR-CRV) can significantly reduce the need for subsequent ischemia-driven revascularization (ID-RV), but it has no significant impact on mortality or reinfarction. The core questions of this substudy: … Read more